KAD Clinical Research

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Crohn's disease2 trials
• Ulcerative colitis2 trials
• Fatty liver disease (MASLD/MASH)1 trial

Phase

• Phase 24 trials

Status

• Recruiting4 trials

Lead sponsor

• Eli Lilly and Company3 trials
• Rivus Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  NCT07483073· Phase 2· Eli Lilly and Company· Source

  Contact: Adrian Di Bisceglie (principal investigator)

• Recruiting

  A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  NCT07483099· Phase 2· Eli Lilly and Company· Source

  Contact: Adrian Di Bisceglie (principal investigator)

• Recruiting

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· Phase 2· Eli Lilly and Company· Source

  Contact: Adrian Di Bisceglie (principal investigator)

• Recruiting

  A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

  NCT07491458· Phase 2· Rivus Pharmaceuticals, Inc.· Source

  Contact: Kristina Wriston

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease2 recruiting
• Ulcerative colitis2 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting